Caribou Biosciences (CRBU) Revenue Growth (3y) (2023 - 2026)
Caribou Biosciences (CRBU) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 54.05% |
| 10 | Caribou Biosciences | 154.82 Mn | 37.19 Mn | - | -11.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.87% |
| Dec 31, 2025 | 2.20% |
| Sep 30, 2025 | -12.69% |
| Jun 30, 2025 | -13.99% |
| Mar 31, 2025 | -4.05% |
| Dec 31, 2024 | -6.72% |
| Sep 30, 2024 | -20.16% |
| Jun 30, 2024 | 32.89% |
| Mar 31, 2024 | 15.27% |
| Dec 31, 2023 | 53.49% |
| Sep 30, 2023 | 170.31% |
| Jun 30, 2023 | -23.77% |
| Mar 31, 2023 | 27.21% |